• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Technology Bio Tech

Respiri Share Price Jumps on Manufacturing Deal (ASX:RSH)

Like 0

By Carl Wittkopp, Tuesday, 22 September 2020

At time of writing, the Respiri Ltd [ASX:RSH] share price is up 4.55%, trading at 23 cents. The Melbourne-based biotech company recently announced a manufacturing partner for their new product, wheezo™...

At time of writing, the Respiri Ltd [ASX:RSH] share price is up 4.55%, trading at 23 cents.

The Melbourne-based biotech company recently announced a manufacturing partner for their new product, wheezo™.

With recent positive clinical study results, the company also completed the search for a manufacturing partner.

ASX RSH Share price chart 1

Source: Optuma

What’s happening at Respiri?

Respiri is working on a new product that is showing promising signs of being able to detect wheezing in patients.

The company recently announced positive preliminary results of a clinical study comparing wheezo™ to the standard clinician-based stethoscope measurement of wheezing associated with asthma and chronic obstructive pulmonary disease.

With the encouraging results in hand, the next natural step was to find a manufacturing partner for the new product.

Today, the company announced their search was complete and that they had appointed Entech Electronics as the global manufacturing partner for wheezo™

Entech Electronics are Australian based.

Operating in Devon Park, South Australia, the company has operated offshore production facilities in Shenzhen China since 2006.

Respiri have placed initial orders for manufacturing to begin with 12,000 devices commissioned for delivery in February 2021.

Marjan Mikel, Respiri’s CEO and Managing Director, commented:

‘We are delighted to partner with Entech Electronics as they are well placed to support our global product volume requirements at cost positions that support Respiri’s business model.’

Where to from here for Respiri?

Since May the RSH share price rose significantly. On the back of the most recent news, I would not be surprised if this trend continues — such is the strong upward momentum.

ASX RSH - Respiri Share Price Chart 2

Source: Optuma

With the RSH share price trading very close to the most recent high at the time of writing, the chart looks bullish, and should the RSH share price keep moving up, then the levels of 24 and 25 cents may come into play.

On the other hand, if the price were to start to fall back, then the levels of 21 and 19 cents may become the focus in the short term.

The current trend in Australia towards medtech could be a major investing theme on the ASX for years to come.

Recent coverage in the Australian Financial Review suggested it is now our largest manufacturing export worth over $8.2 billion annually.

But there are other trends to watch as well, particularly in e-commerce and safety technology.

Get the names of four companies operating across these two trends in this excellent free small-caps report.

It’s a must read.

Regards,

Carl Wittkopp,
For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Carl Wittkopp

Carl’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • As Political Dumb-Wits Beat the Drums of War: Keep Commodities Front and Centre
    By James Cooper

    In today’s edition, James Cooper looks at the growing hostilities between Pakistan and India through the lens of the commodity cycle. And why it could matter more than most think.

  • The share market bears have no answer to this…
    By Callum Newman

    I came across a handy bit of info from Wilson Asset Management yesterday. Wilson says that there’s strong demand for Chinese assets despite the recent volatility and trade tensions. Why do we care? There could be profit in this.

  • The method in Trump’s tariff madness
    By Jim Rickards

    Trump is pursuing a twenty-first-century version of what was originally known as the American System. A system that made America great in the first place.

Primary Sidebar

Latest Articles

  • As Political Dumb-Wits Beat the Drums of War: Keep Commodities Front and Centre
  • The share market bears have no answer to this…
  • The method in Trump’s tariff madness
  • The first place to look thanks to the US/China truce
  • The trade war is over. Tax cut chaos is next.

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988